Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01094366 · ClinicalTrials.gov registry record · Phase 4
Paracervical Block for Pain Control in First Trimester Abortion
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 121
- Enrollment target
NCT01094366 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 121 participants.
The verdict
NCT01094366, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 121 participants
- Enrollment target
Study Summary
Many woman undergoing a surgical abortion receive a paracervical nerve block for pain reduction, in which lidocaine (a numbing medication) is injected around the cervix. These injections numb the cervix and possibly the lower part of the uterus. However, the injection can be uncomfortable and it is not well known whether it is effective in reducing pain. The purpose of this study is to determine the level of pain women experience with a surgical abortion and the effect that paracervical block might have on that pain.
Interventions
- PROCEDURE Paracervical Block
- PROCEDURE Sham Paracervical Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01094366
The ClinicalTrials.gov registry entry for NCT01094366 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Paracervical Block is the first listed.
NCT01094366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01094366 about?
NCT01094366 is a clinical study titled "Paracervical Block for Pain Control in First Trimester Abortion". Many woman undergoing a surgical abortion receive a paracervical nerve block for pain reduction, in which lidocaine (a numbing medication) is injected around the cervix. These injections numb the cervix and possibly the lower part of the uterus. However, the injection can be uncomfortable and it is ...
What is the current status of trial NCT01094366?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 121 participants. The study started on 2010-04. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01094366?
The interventions under investigation include: Paracervical Block (PROCEDURE), Sham Paracervical Block (PROCEDURE).
Who is sponsoring clinical trial NCT01094366?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.